Hello, Fool! | Login | Signup | My Fool
Oct 10, 2008 10:41 PM ET | Feedback | Site Changes | Help
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
View All Commentary (AZN)
Recs
Rightime (87.73) Submitted: 9/13/06 6:44 AM : Start Price: $57.88 AZN Score: 4.18
AstraZeneca halted development of two new drug candidates: Galida for diabetes and Exanta for blood clotting. Nexuim may face pressure from prilosec due to cost by insurance companies. Crestor is a good play.
Report this Post Replies: 1 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
tommycarstensen (< 20) Submitted: 2/23/08 8:23 AM
Recs: 0 | Rec This
What is your oppinion about the acquisition of MedImmune? I personally think $15.6 bln was a lot to pay for revenue of less than $2 bln per year.
Report this Post Reply
Terms & Conditions
RSS Headlines
Fool UK